Association of programmed death ligand-1 (PD-L1) expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib.
| Image |  |
|---|---|
| Description | scientific article published on 20 November 2017 |
| Author/s |
author: Matthew J Wongchenko Brigitte Dréno Grant McArthur James Larkin Paolo Antonio Ascierto Antoni Ribas |
| Publication date | November 20, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |